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The prevalence of Alzheimer disease (AD) doubles every 5 years after the age of 65,
reaching nearly 50% after age 85 (Evans et al., 1989). This, along with an unprecedented
growth in the elderly population, is leading to dramatic increases in the incidence of AD.
Thus, effective strategies for promoting healthy brain aging and preventing AD are
increasingly important. One strategy that appears promising in promoting healthy brain
aging is exercise and physical activity. Evidence is accumulating that endurance exercise is
beneficial to brain health (Laurin, Verreault, Lindsay, MacPherson, & Rockwood, 2001),
and increased cardiorespiratory fitness is associated with increased brain volume in subjects
with very mild to mild AD (Burns et al., 2008).
While enhancing cardiorespiratory fitness may be a strategy for preventing cognitive decline
in AD, there is limited information available on the validity and reliability of
cardiorespiratory fitness measures in this population. The gold standard measure of
cardiorespiratory fitness is maximum oxygen consumption (VO2max) (Frankin, 2001), the
highest rate of oxygen uptake attainable during maximal or exhaustive exercise (American
College of Sports Medicine, 2005). If the subject becomes exhausted and ends the test prior
to reaching the physiologic VO2max, the end of the test is called peak oxygen consumption
(VO2peak). It is unknown if advanced age and cognitive difficulties in people with AD
would limit their ability to fully participate in a standard graded exercise test to reliably
assess VO2max or VO2peak.
Treadmill exercise testing has been found to be reliable in subjects with traumatic brain
injury and mental retardation, although these subjects were very young (Fernhall, Millar,
Tymeson, & Burkett, 1990; Mossberg & Greene, 2005). Traumatic brain injury and mental
retardation are different disease processes than AD and would be expected to result in static
rather than progressive cognitive symptoms. With AD, memory is impaired as is the ability
to follow commands, however patients in the earliest stages of AD would be expected to
respond to prompting and reminders to follow testing procedures. To our knowledge, no
studies have assessed the reliability of peak treadmill exercise testing in subjects with AD.
In our previous research on patients with very mild to mild AD (Burns, et al., 2008), we
have found them to be capable of ambulating on a treadmill and completing peak treadmill
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exercise testing with 3 participants out of 74 (126 total peak exercise tests) identified as
having EKG changes during testing. All 3 participants had negative follow-up testing in
cardiology. The purpose of this study was to investigate the reliability of a graded peak
treadmill exercise test in elderly people with early AD.
Method
Study Design
A sample of convenience was used to investigate test-retest reliability of VO2peak
assessment using a graded peak exercise test on a treadmill. The VO2peak test was performed
twice within a 14-day period.
Participants
Sixteen subjects (11 men, 5 women) enrolled in the University of Kansas Brain Aging
Project participated in this study. This program, which is a longitudinal study of brain health
in community dwelling older adults with and without dementia has been previously
described (Burns et al., 2007). Subject qualifications for participating in the current study
included 1) age 60 years or older, 2) diagnosis of Probable AD according to the National
Institute of Neurological and Communicative Disorders and Stroke-Alzheimer Disease and
Related Disorders Association (NINDS-ADRDA),(McKhann et al., 1984) and 3) Clinical
Dementia Rating (CDR)(Hughes, Berg, Danziger, Coben, & Martin, 1982; Morris, 1993) of
0.5 (very mild) or 1 (mild dementia). The stringent clinical diagnostic criteria for AD
utilized in this study has a diagnostic accuracy for AD of 93% (Berg et al., 1998). Subjects
were excluded if they had myocardial infarction or symptoms of coronary artery disease
(e.g., angina) in the last two-years or uncontrolled hypertension within the last 6 months. All
subjects or their legally acceptable representative gave written, informed consent to
participate in the study. The institutional review board of the University of Kansas Medical
Center approved all procedures.
Exercise Test Protocol
Each subject completed two identical symptom-limited incremental exercise tests to
voluntary fatigue over a 14-day period in the presence of a physician, an exercise
physiologist, a research assistant, and a nurse. The instrumentation and procedure for
treadmill testing described by Mossberg (Mossberg & Greene, 2005) was modified to
include use of the Trackmaster TMX425 treadmill (Full Vision, Inc, Newton KS), 12-lead
electrocardiograph system (Cardio-Card, Nasiff Associates, Brewerton, NY), and 2-way
valve mouthpiece (Hans Rudolph, Inc., Shawnee, KS) attached to an automated metabolic
measurement cart (TrueOne 2400, ParvoMedics, Sandy, UT) where respiratory gas
exchange data for oxygen consumption (VO2) and RER were averaged over 15-second
intervals. Prior to beginning peak exercise testing, subjects and their spouses were
administered a modified Physical Activity Readiness Questionnaire (PAR-Q) (S. Thomas,
Reading, & Shephard, 1992) to assess possible safety concerns before beginning the graded
exercise testing. Resting data were collected for at least 30 seconds with the patient standing
on the treadmill to allow CO2 levels to stabilize and to familiarize the subject with the
mouthpiece, then the patient began walking at a pace of 1.7 mph at 0% grade. The Modified
Bruce protocol was used for the peak exercise test, (Okin, Ameisen, & Kligfield, 1986) and
the grade was increased by 5% every 2 minutes up to 10% grade at which point speed was
increased by 0.4 mph and grade by 1% every 2 minutes. Borg Rating of Perceived Exertion
(RPE) and blood pressure were recorded at the end of each stage.
American College of Sports Medicine (ACSM) guidelines (American College of Sports
Medicine, 2005) were used to determine whether the exercise test should be terminated early
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and included ST-segment depression of more than 2mm, increasing nervous system
symptoms (ie, ataxia, dizziness), sustained ventricular tachycardia, and chest discomfort.
Exercise was continued until (1) objective signs required termination of the test (e.g.,
electrocardiogram abnormality, (2) the cardiorespiratory responses failed to increase
normally with increasing workload or (3) patients could not continue to exercise at the
prescribed workload despite encouragement to do so.
Patients were verbally encouraged to give their maximal effort as they approached the end
of the test. On termination of exercise, patients continued walking at a speed less than or
equal to 1.7 mph and 0% grade until blood pressure and heart rate returned to near pre-
exercise values. After the testing was completed, a blinded exercise physiologist reviewed
the metabolic cart readings and made the determination for VO2peak, the highest VO2 level
recorded within the last 60 seconds of testing. RER and peak heart rate values were taken
from the time of the corresponding VO2peak.
Tests and retests were generally performed in the morning between 2 and 14 days apart,
with the two testing sessions performed at approximately the same time of day (within one
hour). The retest was performed by the same staff members and using the same treadmill as
the initial test. Subjects (and their spouses) were instructed to undergo the same activities
before the second test as they had undertaken before the first test to ensure as much pretest
standardization as possible. This included physical activity, medication administration, and
smoking. Subjects were encouraged to not initiate a new diet or exercise routine between the
test and retest. Subjects fasted for at least 6 hours prior to the test and retest, but were
allowed to hydrate with water ad libitum. Additionally, participants were asked to avoid
caffeine and vigorous physical activity for at least 6 and 24 hours, respectively, prior to
testing.
Data Analysis
Analyses were conducted using SPSS, version 16.0 (SPSS Inc., Chicago, IL). Descriptive
statistics were performed on all measures. The frequency and percentage of participants who
achieved the criteria for VO2max were determined. Intraclass correlation coefficients (ICC
[3,1]) were calculated to determine test-retest reliability, and reliability was calculated using
a two-way random-effects model (the between-time variance is excluded from the
denominator variance). ICC [2,1] (where the between-time variance is included in the
denominator variance) was also calculated. Paired t tests were used to determine significant
differences between trials with respect to VO2peak, RER, test duration, and peak heart rate.
Standard error of measurement (SEM), the average error (Hopkins, 2000) or mean deviation
from the mean, complements ICCs in studies of reliability (Shrout, 1998) where ICCs
provide information on relative reliability and SEM on absolute reliability. SEM was
calculated as the standard deviation of the sample pooled between subjects × √(1-ICC).
Continuous variables are summarized by means and standard deviations, whereas
categorical variables are summarized by frequency and percent.
Although the purpose of this study was to determine the reliability of exercise testing in
subjects with early AD, we assessed the participants’ ability to reach maximum aerobic
capacity (ie, VO2max) during the graded peak exercise test. To determine if VO2max was
reached, participants had to meet three criteria including (1) a leveling off (plateau) or no
change in VO2 with increasing workload, (2) heart rate within 10 beats of age-predicted
maximum heart rate (calculated as 208-(0.7 × age), (Tanaka, Monahan, & Seals, 2001) and
(3) elevated respiratory exchange ratio (RER). The ACSM, 8th edition (ACSM, 2010)
recommends RER > 1.1, however the criteria for establishing maximal exercise testing in
older adults is inconsistent in the literature, ranging from greater than 1.0 (da Cunha-Filho et
al., 2001) to 1.15 (Eng, Dawson, & Chu, 2004; Howley, Bassett, & Welch, 1995). We
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therefore applied an RER cut-off value of >1.0 as a criterion for determining VO2max. β-
blockers may reduce heart rate by 25% to 30% (Tesch, 1985), so as in Tang, et al,(Tang,
Sibley, Thomas, McIlroy, & Brooks, 2006) for the subjects on β-blockers, the age-predicted
maximal heart rate was adjusted according to the equation (0.7 × (220-age)).
Results
Patients’ physical characteristics and severity of dementia as represented by the Clinical
Dementia Rating Scale (CDR) are summarized in Table 1. CDR scores were determined an
average of 5.7 months prior to entering the study, and the dementia severity is expected to
have declined very little over the 5.7 months (Aisen et al., 2008; Rogers, Farlow, Doody,
Mohs, & Friedhoff, 1998; Tariot et al., 2001). The graded treadmill test and re-test were
performed an average of 3.2 days apart (range: 2 to 7 days).
Sixteen subjects were contacted to participate in the study, and all 16 individuals met
inclusion criteria and agreed to participate in the study. All 16 participants felt comfortable
walking on the treadmill, and none of the participants required the use of the familiarization
session. No additional personnel were required beyond the standard testing personnel, and
no additional safety precautions were necessary. Two subjects (12.5%) did not complete the
first of the two treadmill exercise tests. One woman (CDR 0.5, age 73 years) was withdrawn
due to excessive sweating and possible ST segment depression, however evaluation during a
formal cardiology consult revealed a normal exercise EKG. The other woman (CDR 1, age
78 years) was withdrawn due to ST segment depression.
Fourteen (87.5%) participants completed both graded peak exercise tests without incident.
Of these, exercise testing was terminated by all subjects due to subjective report of fatigue.
Three of the subjects (21%) reached the predicted maximal heart rate, and 5 additional
subjects (total of 57%) reached a peak heart rate within 10 beats per minute of the age-
predicted maximal heart rate. With respect to the other 2 criteria for VO2max, 14 (100%)
participants showed a plateau in VO2 at the end of the initial test and the retest, and 13
(93%) reached an RER value greater than 1.0 (1 participant reached an RER of 1.0). Data
from these 14 subjects (11 men, 3 women) were included in the reliability analysis.
Peak Cardiorespiratory Responses During Incremental Exercise
As noted above, two of the patients enrolled had signs and symptoms that required
termination of the first test. The remaining 14 subjects continued to exercise to voluntary
fatigue. The descriptive characteristics of the exercise testing and reliability results are
presented in Table 2. Figure 1 illustrates the relationship between test and retest for VO2peak.
Reliability of the Peak Cardiorespiratory Responses
Reliability was excellent with total VO2peak (mL/kg/min) highly correlated across the two
tests (r=0.94, p<0.001) with an intraclass correlation coefficient (ICC [3,1]) of 0.92. Other
measures such as exercise duration (r=0.93, p<0.001; ICC [3,1] =0.92) and maximum heart
rate (r=0.87, p<0.001; ICC [3,1] = 0.87) had excellent reliability. Low ICC values were
noted for RER, possibly because of the low variability in the measure. There was a
statistically significant difference between test and retest for exercise duration. The SEM
data are presented in Table 2. Noted is the point estimates for ICC [2,1] were very similar to
ICC [3,1].
Discussion
To our knowledge, the reliability of peak exercise testing has not been previously reported in
patients with mild AD. Our data demonstrate that this testing procedure is reliable in this
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population. Although two subjects (12.5%) were not able to complete the test because of
cardiac concerns, our previous experience with exercise testing in subjects in the earliest
stages of AD (Burns, et al., 2008) has shown a very low incidence of cardiac concerns (2%)
during peak treadmill exercise testing.
Although the ACSM criteria for a maximal exercise test include plateau in VO2, elevated
RER, and peak heart rate within 10 beats per minute of age-predicted maximal heart rate
(ACSM, 2010), these criteria are not specific to older adults or those individuals with
dementia. Because peak heart rate can be influenced by the use of β-blockers and
determination of plateau in VO2 is subjective, we feel that the most important physiologic
criteria is RER. Among the subjects who did complete our exercise protocol, 11 (78.6%)
met all three of our criteria for maximal effort as described in Data Analysis above (plateau
in VO2, RER > 1.0, and peak heart rate within 10 beats per minute of age-predicted
maximal heart rate), and 13 (92.9%) achieved RER > 1.0. The fourteenth subject achieved
RER = 1.0. In a study of maximal exercise testing in subacute stroke patients, only 2.9%
reached criteria for maximal exercise testing using criteria which included reaching an RER
>1.0 (Tang, et al., 2006). Information regarding medical comorbidities such as
cardiovascular or pulmonary conditions was not provided for the subacute stroke patients,
however the subjects enrolled in our study are generally healthy with no diabetes, heart
disease, or stroke. Perhaps underlying medical conditions along with limb fatigue from
hemiparesis following stroke in Tang et al (Tang, et al., 2006) influenced their capacity to
reach maximal exercise testing. Four of our patients were taking β-blockers during the
testing period, and the age-predicted heart rate for these subjects was adjusted to 70%. Using
this adjustment, three of these four subjects reached predicted heart rates. The average
duration of our test was within the recommended guidelines for graded maximal exercise
testing of 8–12 minutes (ACSM, 2010).
Reliability studies help researchers understand the measurement error “inherent in any
diagnosis, score, or measurement (Kottner et al., 2011).” ICC’s are “for measuring the
reliability of continuous scales (Kottner, et al., 2011).” Low reliability will result in an
unacceptable amount of noise and can affect the power to detect differences in clinical trials
or cause bias when using such variables as predictors (e.g. in a regression analysis). We
found the variables exercise duration, heart rate, and VO2 (ml/kg/min) to have moderate
reliability, VO2 (l/min) has substantial reliability, and RER is inconclusive, but lower than
VO2 (l/min). More work is needed to refine the understanding of the absolute reliability of
RER. Our results were identical to the reliability of maximal exercise testing in individuals
with traumatic brain injury (Mossberg & Greene, 2005) and comparable to those in
individuals with mental retardation (Fernhall, et al., 1990) with respect to ICCs for VO2 (ml/
kg/min), and our results showed higher levels of reliability compared to a study in older
women (Foster, Hume, Dickinson, Chatfield, & Byrnes, 1986) and in older men (S. G.
Thomas, Cunningham, Rechnitzer, Donner, & Howard, 1987) with respect to Pearson
correlations for VO2peak (ml/kg/min). Average VO2peak (ml/kg/min) in our study was
similar compared to a group of men (20.9 vs. 20.5) and women (17.0 vs. 16.6) (Paterson,
Cunningham, Koval, & St Croix, 1999) age 75–79.
Although we found excellent consistency of most measures between the tests, we did find a
statistically significant difference in duration between tests. Although duration is frequently
reported as an outcome measure (Lyerly et al., 2008; Pollock et al., 1976; Sui et al., 2009)
this is not a true measure of cardiorespiratory fitness and may reflect patient comfort with
the test and willingness to continue beyond the point of VO2 plateau. There was also an
increase in performance from trial one to trial two which might be considered a limiting
factor on the accuracy of the absolute reliability of the procedure, however there was no
statistically significant change in VO2peak between trial one and trial two. Although the
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mean test duration was within the recommended guidelines for graded maximal exercise
testing of 8–12 minutes (ACSM, 2010), 10 of 28 tests were less than 8 minutes in duration.
Therefore a different protocol with more gradual workload increases or a bicycle ergometer
may be useful for future research studies.
A limitation to the study is the small sample size which limits the study’s generalizability.
There are other limitations to this study as well. Eleven men but only 3 women completed
the test and retest however the numbers are too small to perform subgroup analysis to detect
differences between men and women on results. Clinical Dementia Rating (CDR) scoring
was performed an average of 5.7 months prior to the exercise tests. The CDR was not a
primary outcome measure for this study and was only used to characterize participants as
having early-stage Alzheimer disease. Dementia severity is expected to have declined very
little over the 5.7 months (Aisen, et al., 2008; Rogers, et al., 1998; Tariot, et al., 2001). The
sample was limited to early-stage AD and is not clearly generalizable to more advanced AD.
Subjects with more advanced dementia may have greater variability in fatigue tolerance or
may have more difficulty understanding directions for exercise testing. Finally, these
individuals were cardiovascularly healthy and did not have significant orthopedic conditions
limiting their ability to participate in fitness testing.
Nevertheless these data provides the first evidence that peak exercise testing on the treadmill
is a reliable method of investigating cardiorespiratory fitness in individuals with early stage
AD. Future work to explore physical fitness in patients with AD should utilize this testing
protocol with confidence to identify changes as a result of an exercise intervention. This
study is an important first step to establishing appropriate testing protocols for exercise
testing in subjects with mild AD.
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Scatterplot showing relationship between test and retest peak exercise responses in patients
with very mild to mild AD (N=14) measured in mL/kg/min.
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Table 1
Descriptive characteristics of subjects with very mild to mild Alzheimer disease who completed peak treadmill
test and retest (n=14)
Variable Values Range
Men/women 9/5
Clinical Dementia Rating 0.5–1
 CDR 0.5 9
 CDR 1 5
 Sum of Boxes 3.9 ± 1.5 2.0–7.0
Age at test, yrs 77 ± 4.8 70–84
β-blockers (%) 4 (29%)
Height, cm 171.6 ± 9.7 157.0–188.0
Weight, kg 72.6 ± 9.4 63.4–95.9
Body mass index, kg/m2 24.7 ± 3.1 20.0–29.5
NOTE. Values are n or mean ± standard deviation (SD) (range) unless noted otherwise.
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